Austria · Delayed Price · Currency is EUR Eckert & Ziegler SE Company Description
Eckert & Ziegler SE manufactures and sells isotope technology components worldwide.
It operates through two segments, Medical and Isotope Products. The company provides small implants for the treatment of prostate cancer seeds; and eye applicators based on ruthenium-106 and iodine-125 for the treatment of uveal melanomas; brain seed, HDR and brachytherapy; ophthalmological products; therapeutic and radiotherapy accessories, X-Ray therapy, GA-68 generators, radiochromatography, hot cells; and radiopharmaceuticals, laboratory equipment, radiosynthesis equipment, quality-control equipment, consumables, therapeutic products and plant engineering, and other services.
It offers standard and radiation sources for medical and industrial sectors; medical imaging and spect diagnostics, industrial analytical and instrument, high activity CS-137 and CO-60, and oil well logging sources; blood irradiators and environmental disposal source services; and bulk isotopes as well as calibration related sources for radioisotopes.
It serves medical, scientific, and industrial applications. The company was formerly known as Eckert & Ziegler Strahlen- und Medizintechnik AG and changed its name to Eckert & Ziegler SE in March 2024.
Eckert & Ziegler SE was founded in 1992 and is headquartered in Berlin, Germany.
| Country | Germany |
| Founded | 2024 |
| Industry | Industrial Inorganic Chemicals |
| Employees | 1,085 |
| CEO | Harald Hasselmann |
Contact Details
Address: Robert-ROessle-Str. 10 Berlin, 13125 Germany | |
| Phone | 49 30 94 10 84 0 |
| Website | ezag.com |
Stock Details
| Ticker Symbol | EUZG |
| Exchange | Vienna Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | EUR |
| SIC Code | 2810 |
Key Executives
| Name | Position |
|---|---|
| Harald Hasselmann | Chief Executive Officer |